Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia

首页> 外文期刊>British Journal of Haematology >Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia

【24h】

Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia

机译：白细胞介素-6对慢性骨髓白血病患者患者Covid-19相关细胞因子释放综合征的白细胞介素-6封闭治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《British Journal of Haematology》 |2020年第3期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词
tocilizumab; coronavirus; chronic myeloid leukaemia;

机译：Tocilizumab;冠状病病毒;慢性骨髓白血病;

相似文献

外文文献
中文文献
专利

1. Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia [J] . British Journal of Haematology . 2020,第3期

机译：白细胞介素-6对慢性骨髓白血病患者患者Covid-19相关细胞因子释放综合征的白细胞介素-6封闭治疗
2. Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management. [J] . Martinelli G, Iacobucci I, Soverini S, Hematological oncology . 2006,第4期

机译：监测伊马替尼治疗慢性粒细胞白血病患者的最小残留疾病并控制耐药性，以作为临床管理的指南。
3. Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature [J] . Amlani Adam, Barber Claire, Fifi-Mah Aurore, The oncologist . 2020,第7期

机译：在从免疫检查点转移到MEK / BRAF抑制的患者中，用IL-6阻断成功治疗细胞因子释放综合征的患者：文学案例报告和审查
4. Enhancement of the Immune Response to Chronic Myeloid Leukaemia via Controlled Treatment Scheduling [C] . H. Chang, A. Astolfi Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2009

机译：通过受控治疗调度增强免疫应答对慢性髓性白血病的影响
5. gamma-Aminobutyric acid inhibits cytokine-mediated synergistic induction of astrocytic interleukin-6 release: A mechanistic study. [D] . Aguinaldo, Grant Toshio. 2006

机译：γ-氨基丁酸抑制细胞因子介导的星形胶质细胞白细胞介素6释放的协同诱导：一项机理研究。
6. Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review) [O] . Jia-Jie Chen, Li-Na Zhang, Hu Hou, 2021

机译：白细胞介素-6 Covid-19中细胞因子释放综合征的信号阻断治疗（审查）
7. Interleukin‐6 blockade treatment for COVID‐19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia [O] . Amita Ranger, Ruby Haji, Richard Kaczmarski, 2020

机译：白细胞介素-6对慢性骨髓白血病患者患者Covid-19相关细胞因子释放综合征的白细胞介素-6封闭治疗

Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia

著录项

引文网络

相似文献

相关主题

期刊订阅